LEADER 03688nam  2200685Ia 450 
001 9910828027703321
005 20240508083854.0
010   $a1-118-04355-3
010   $a1-282-65368-7
010   $a9786612653681
010   $a0-470-64046-4
010   $a0-470-64045-6
035   $a(CKB)2670000000031669
035   $a(EBL)547169
035   $a(OCoLC)654805703
035   $a(SSID)ssj0000412841
035   $a(PQKBManifestationID)11913158
035   $a(PQKBTitleCode)TC0000412841
035   $a(PQKBWorkID)10388453
035   $a(PQKB)10945061
035   $a(MiAaPQ)EBC547169
035   $a(Au-PeEL)EBL547169
035   $a(CaPaEBR)ebr10419149
035   $a(CaONFJC)MIL265368
035   $a(EXLCZ)992670000000031669
100   $a20100203d2010      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aBiofilm eradication and prevention $ea pharmaceutical approach to medical device infections /$fTamilvanan Shunmugaperumal
205   $a1st ed.
210   $aOxford $cWiley-Blackwell$d2010
215   $a1 online resource (448 p.)
300   $aDescription based upon print version of record.
311   $a0-470-47996-5 
320   $aIncludes bibliographical references and index.
327   $aBIOFILM ERADICATION AND PREVENTION; CONTENTS; PREFACE; ACKNOWLEDGMENTS; PART I. DEVELOPMENT AND CHARACTERIZATION OF BIOFILMS; 1. INTRODUCTION AND OVERVIEW OF BIOFILM; 2. RATIONALE FOR BIOFILM ERADICATION FROM MODERN MEDICAL DEVICES; 3. PATHOGENESIS OF DEVICE-RELATED NOSOCOMIAL INFECTIONS; 4. BIOFILM RESISTANCE-TOLERANCE TO CONVENTIONAL ANTIMICROBIAL AGENTS; 5. ANALYTICAL TECHNIQUES USEFUL TO STUDY BIOFILMS; PART II. BIOFILM-RELATED INFECTIONS IN VARIOUS HUMAN ORGANS (NONDEVICE-RELATED CHRONIC INFECTIONS); 6. BIOFILM-RELATED INFECTIONS IN OPHTHALMOLOGY
327   $a7. BIOFILM-RELATED INFECTIONS IN THE ORAL CAVITY8. IMPLICATIONS OF BIOFILM FORMATION IN CHRONIC WOUNDS AND IN CYSTIC FIBROSIS; PART III. DRUG DELIVERY CARRIERS TO ERADICATE BIOFILM FORMATION ON MEDICAL DEVICES; 9. STRATEGIES FOR PREVENTION OF DEVICE-RELATED NOSOCOMIAL INFECTIONS; 10. LIPOSOMES AS DRUG DELIVERY CARRIERS TO BIOFILMS; 11. POLYMER-BASED ANTIMICROBIAL DELIVERY CARRIERS; INDEX
330   $aBiofilm Eradication and Preventions presents the basics of biofilm formation on medical devices, diseases related to this formation, and approaches pharmaceutical researchers need to take to limit this problem. Split into three parts, the first deals with the development and characterization of biofilm on the surfaces of implanted or inserted medical devices. Questions as to why biofilms form over medical device surfaces and what triggers biofilm formation are addressed. In the second section, the author discusses biofilm-mediated chronic infections occurred in various organs (eyes, mou
606   $aMedical instruments and apparatus$xMicrobiology
606   $aBiofilms
606   $aMedical instruments and apparatus$xSterilization
606   $aAnti-infective agents$xTherapeutic use
606   $aDrug carriers (Pharmacy)$xTherapeutic use
615  0$aMedical instruments and apparatus$xMicrobiology.
615  0$aBiofilms.
615  0$aMedical instruments and apparatus$xSterilization.
615  0$aAnti-infective agents$xTherapeutic use.
615  0$aDrug carriers (Pharmacy)$xTherapeutic use.
676   $a610.284
700   $aShunmugaperumal$b Tamilvanan$01594535
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910828027703321
996   $aBiofilm eradication and prevention$94119531
997   $aUNINA